nodes	percent_of_prediction	percent_of_DWPC	metapath
Mycophenolate mofetil—IMPDH2—Tioguanine—hematologic cancer	0.133	0.284	CbGbCtD
Mycophenolate mofetil—UGT1A1—hematologic cancer	0.125	0.49	CbGaD
Mycophenolate mofetil—IMPDH1—Tioguanine—hematologic cancer	0.106	0.226	CbGbCtD
Mycophenolate mofetil—ABCG2—hematologic cancer	0.0703	0.275	CbGaD
Mycophenolate mofetil—ALB—hematologic cancer	0.0306	0.12	CbGaD
Mycophenolate mofetil—ABCB1—hematologic cancer	0.0292	0.115	CbGaD
Mycophenolate mofetil—CES2—Irinotecan—hematologic cancer	0.0272	0.0579	CbGbCtD
Mycophenolate mofetil—CES1—Irinotecan—hematologic cancer	0.00944	0.0201	CbGbCtD
Mycophenolate mofetil—ABCG2—Clofarabine—hematologic cancer	0.00919	0.0196	CbGbCtD
Mycophenolate mofetil—UGT1A1—Nilotinib—hematologic cancer	0.00682	0.0145	CbGbCtD
Mycophenolate mofetil—ABCC2—Daunorubicin—hematologic cancer	0.00596	0.0127	CbGbCtD
Mycophenolate mofetil—UGT1A9—Irinotecan—hematologic cancer	0.00573	0.0122	CbGbCtD
Mycophenolate mofetil—UGT2B7—Epirubicin—hematologic cancer	0.00557	0.0119	CbGbCtD
Mycophenolate mofetil—ABCG2—Daunorubicin—hematologic cancer	0.00539	0.0115	CbGbCtD
Mycophenolate mofetil—UGT1A1—Irinotecan—hematologic cancer	0.00468	0.00999	CbGbCtD
Mycophenolate mofetil—ABCG2—Teniposide—hematologic cancer	0.00468	0.00998	CbGbCtD
Mycophenolate mofetil—ABCG2—Cladribine—hematologic cancer	0.00449	0.00956	CbGbCtD
Mycophenolate mofetil—ABCG2—Imatinib—hematologic cancer	0.00413	0.00879	CbGbCtD
Mycophenolate mofetil—UGT1A1—Etoposide—hematologic cancer	0.00375	0.008	CbGbCtD
Mycophenolate mofetil—ABCG2—Nilotinib—hematologic cancer	0.00375	0.00799	CbGbCtD
Mycophenolate mofetil—ABCG2—Dasatinib—hematologic cancer	0.00331	0.00706	CbGbCtD
Mycophenolate mofetil—ABCB1—Lenalidomide—hematologic cancer	0.00331	0.00706	CbGbCtD
Mycophenolate mofetil—ABCG2—Mitoxantrone—hematologic cancer	0.00327	0.00698	CbGbCtD
Mycophenolate mofetil—SLCO1B1—Irinotecan—hematologic cancer	0.00324	0.00691	CbGbCtD
Mycophenolate mofetil—CYP2C8—Bortezomib—hematologic cancer	0.003	0.00639	CbGbCtD
Mycophenolate mofetil—CYP3A5—Daunorubicin—hematologic cancer	0.00298	0.00636	CbGbCtD
Mycophenolate mofetil—SLCO1B3—Methotrexate—hematologic cancer	0.00295	0.00628	CbGbCtD
Mycophenolate mofetil—ABCC2—Irinotecan—hematologic cancer	0.00285	0.00608	CbGbCtD
Mycophenolate mofetil—ALB—Imatinib—hematologic cancer	0.00284	0.00606	CbGbCtD
Mycophenolate mofetil—UGT1A7—hematopoietic system—hematologic cancer	0.00281	0.0922	CbGeAlD
Mycophenolate mofetil—CYP3A5—Thalidomide—hematologic cancer	0.00272	0.00579	CbGbCtD
Mycophenolate mofetil—CYP3A5—Teniposide—hematologic cancer	0.00259	0.00553	CbGbCtD
Mycophenolate mofetil—ABCG2—Irinotecan—hematologic cancer	0.00258	0.00549	CbGbCtD
Mycophenolate mofetil—ABCC2—Vinblastine—hematologic cancer	0.00253	0.0054	CbGbCtD
Mycophenolate mofetil—ABCC2—Vincristine—hematologic cancer	0.00249	0.00531	CbGbCtD
Mycophenolate mofetil—CYP3A5—Ifosfamide—hematologic cancer	0.00239	0.0051	CbGbCtD
Mycophenolate mofetil—ABCC2—Cisplatin—hematologic cancer	0.00232	0.00495	CbGbCtD
Mycophenolate mofetil—CYP2C8—Ifosfamide—hematologic cancer	0.0023	0.0049	CbGbCtD
Mycophenolate mofetil—CYP3A5—Imatinib—hematologic cancer	0.00229	0.00487	CbGbCtD
Mycophenolate mofetil—ABCC2—Etoposide—hematologic cancer	0.00228	0.00487	CbGbCtD
Mycophenolate mofetil—ABCG2—Vincristine—hematologic cancer	0.00225	0.0048	CbGbCtD
Mycophenolate mofetil—ABCG2—Cisplatin—hematologic cancer	0.0021	0.00448	CbGbCtD
Mycophenolate mofetil—ABCG2—Etoposide—hematologic cancer	0.00206	0.0044	CbGbCtD
Mycophenolate mofetil—CYP2C8—Nilotinib—hematologic cancer	0.002	0.00426	CbGbCtD
Mycophenolate mofetil—CYP3A4—Bexarotene—hematologic cancer	0.00198	0.00423	CbGbCtD
Mycophenolate mofetil—ABCB1—Daunorubicin—hematologic cancer	0.00194	0.00414	CbGbCtD
Mycophenolate mofetil—ABCB1—Alitretinoin—hematologic cancer	0.0019	0.00406	CbGbCtD
Mycophenolate mofetil—ABCC2—Dexamethasone—hematologic cancer	0.00188	0.004	CbGbCtD
Mycophenolate mofetil—ALB—Prednisone—hematologic cancer	0.00187	0.00399	CbGbCtD
Mycophenolate mofetil—Mycophenolic acid—UGT1A1—hematologic cancer	0.00187	1	CrCbGaD
Mycophenolate mofetil—UGT1A7—blood—hematologic cancer	0.00186	0.0611	CbGeAlD
Mycophenolate mofetil—CYP3A4—Busulfan—hematologic cancer	0.00185	0.00393	CbGbCtD
Mycophenolate mofetil—CYP3A4—Lomustine—hematologic cancer	0.00185	0.00393	CbGbCtD
Mycophenolate mofetil—CYP3A5—Dasatinib—hematologic cancer	0.00184	0.00391	CbGbCtD
Mycophenolate mofetil—ALB—Irinotecan—hematologic cancer	0.00178	0.00379	CbGbCtD
Mycophenolate mofetil—SLCO1B1—Methotrexate—hematologic cancer	0.00172	0.00366	CbGbCtD
Mycophenolate mofetil—ABCG2—Dexamethasone—hematologic cancer	0.0017	0.00362	CbGbCtD
Mycophenolate mofetil—CYP3A4—Thiotepa—hematologic cancer	0.00164	0.00351	CbGbCtD
Mycophenolate mofetil—ABCC2—Doxorubicin—hematologic cancer	0.00156	0.00332	CbGbCtD
Mycophenolate mofetil—ABCC2—Methotrexate—hematologic cancer	0.00151	0.00322	CbGbCtD
Mycophenolate mofetil—ABCB1—Imatinib—hematologic cancer	0.00149	0.00317	CbGbCtD
Mycophenolate mofetil—CYP3A5—Irinotecan—hematologic cancer	0.00143	0.00304	CbGbCtD
Mycophenolate mofetil—ABCG2—Doxorubicin—hematologic cancer	0.00141	0.003	CbGbCtD
Mycophenolate mofetil—ABCG2—Methotrexate—hematologic cancer	0.00136	0.00291	CbGbCtD
Mycophenolate mofetil—ABCB1—Nilotinib—hematologic cancer	0.00135	0.00288	CbGbCtD
Mycophenolate mofetil—ABCB1—Vinorelbine—hematologic cancer	0.00134	0.00286	CbGbCtD
Mycophenolate mofetil—CYP3A4—Methoxsalen—hematologic cancer	0.00128	0.00273	CbGbCtD
Mycophenolate mofetil—CYP3A5—Vincristine—hematologic cancer	0.00125	0.00266	CbGbCtD
Mycophenolate mofetil—CYP3A4—Bortezomib—hematologic cancer	0.00122	0.00259	CbGbCtD
Mycophenolate mofetil—UGT1A6—testis—hematologic cancer	0.0012	0.0393	CbGeAlD
Mycophenolate mofetil—ABCB1—Dasatinib—hematologic cancer	0.00119	0.00255	CbGbCtD
Mycophenolate mofetil—ABCB1—Mitoxantrone—hematologic cancer	0.00118	0.00252	CbGbCtD
Mycophenolate mofetil—CYP3A4—Daunorubicin—hematologic cancer	0.00116	0.00248	CbGbCtD
Mycophenolate mofetil—CYP3A5—Etoposide—hematologic cancer	0.00114	0.00244	CbGbCtD
Mycophenolate mofetil—CYP2C8—Etoposide—hematologic cancer	0.0011	0.00234	CbGbCtD
Mycophenolate mofetil—ABCB1—Betamethasone—hematologic cancer	0.00105	0.00224	CbGbCtD
Mycophenolate mofetil—IMPDH2—hematopoietic system—hematologic cancer	0.00105	0.0344	CbGeAlD
Mycophenolate mofetil—ABCB1—Gemcitabine—hematologic cancer	0.00104	0.00222	CbGbCtD
Mycophenolate mofetil—IMPDH1—hematopoietic system—hematologic cancer	0.00104	0.0341	CbGeAlD
Mycophenolate mofetil—ABCB1—Prednisolone—hematologic cancer	0.00104	0.00221	CbGbCtD
Mycophenolate mofetil—CYP3A4—Cytarabine—hematologic cancer	0.00103	0.00219	CbGbCtD
Mycophenolate mofetil—CYP3A4—Teniposide—hematologic cancer	0.00101	0.00216	CbGbCtD
Mycophenolate mofetil—ABCB1—Prednisone—hematologic cancer	0.00098	0.00209	CbGbCtD
Mycophenolate mofetil—CES2—hematopoietic system—hematologic cancer	0.00095	0.0312	CbGeAlD
Mycophenolate mofetil—CYP3A5—Dexamethasone—hematologic cancer	0.00094	0.002	CbGbCtD
Mycophenolate mofetil—ALB—Methotrexate—hematologic cancer	0.00094	0.002	CbGbCtD
Mycophenolate mofetil—CYP3A4—Ifosfamide—hematologic cancer	0.000933	0.00199	CbGbCtD
Mycophenolate mofetil—ABCB1—Irinotecan—hematologic cancer	0.000929	0.00198	CbGbCtD
Mycophenolate mofetil—CYP2C8—Dexamethasone—hematologic cancer	0.000904	0.00193	CbGbCtD
Mycophenolate mofetil—CYP3A4—Imatinib—hematologic cancer	0.000891	0.0019	CbGbCtD
Mycophenolate mofetil—CYP3A4—Ruxolitinib—hematologic cancer	0.000839	0.00179	CbGbCtD
Mycophenolate mofetil—ABCB1—Vinblastine—hematologic cancer	0.000826	0.00176	CbGbCtD
Mycophenolate mofetil—ABCB1—Vincristine—hematologic cancer	0.000812	0.00173	CbGbCtD
Mycophenolate mofetil—CYP3A4—Nilotinib—hematologic cancer	0.00081	0.00173	CbGbCtD
Mycophenolate mofetil—UGT1A1—hematopoietic system—hematologic cancer	0.000808	0.0266	CbGeAlD
Mycophenolate mofetil—CYP3A4—Vinorelbine—hematologic cancer	0.000803	0.00171	CbGbCtD
Mycophenolate mofetil—IMPDH2—gonad—hematologic cancer	0.000795	0.0261	CbGeAlD
Mycophenolate mofetil—CES1—hematopoietic system—hematologic cancer	0.000783	0.0257	CbGeAlD
Mycophenolate mofetil—ABCB1—Cisplatin—hematologic cancer	0.000757	0.00161	CbGbCtD
Mycophenolate mofetil—ABCB1—Etoposide—hematologic cancer	0.000744	0.00159	CbGbCtD
Mycophenolate mofetil—CYP3A4—Triamcinolone—hematologic cancer	0.000735	0.00157	CbGbCtD
Mycophenolate mofetil—CES2—gonad—hematologic cancer	0.000723	0.0237	CbGeAlD
Mycophenolate mofetil—CYP3A4—Dasatinib—hematologic cancer	0.000716	0.00153	CbGbCtD
Mycophenolate mofetil—CYP3A4—Mitoxantrone—hematologic cancer	0.000707	0.00151	CbGbCtD
Mycophenolate mofetil—IMPDH2—blood—hematologic cancer	0.000693	0.0228	CbGeAlD
Mycophenolate mofetil—IMPDH1—blood—hematologic cancer	0.000688	0.0226	CbGeAlD
Mycophenolate mofetil—SLCO1B3—lung—hematologic cancer	0.000675	0.0222	CbGeAlD
Mycophenolate mofetil—SLCO1B1—hematopoietic system—hematologic cancer	0.000672	0.0221	CbGeAlD
Mycophenolate mofetil—IMPDH2—bone marrow—hematologic cancer	0.00067	0.022	CbGeAlD
Mycophenolate mofetil—IMPDH1—bone marrow—hematologic cancer	0.000666	0.0219	CbGeAlD
Mycophenolate mofetil—CYP3A4—Betamethasone—hematologic cancer	0.00063	0.00134	CbGbCtD
Mycophenolate mofetil—CES2—blood—hematologic cancer	0.00063	0.0207	CbGeAlD
Mycophenolate mofetil—CYP3A4—Prednisolone—hematologic cancer	0.000622	0.00133	CbGbCtD
Mycophenolate mofetil—ABCB1—Dexamethasone—hematologic cancer	0.000612	0.0013	CbGbCtD
Mycophenolate mofetil—CES2—bone marrow—hematologic cancer	0.000609	0.02	CbGeAlD
Mycophenolate mofetil—IMPDH2—lung—hematologic cancer	0.000607	0.02	CbGeAlD
Mycophenolate mofetil—IMPDH1—lung—hematologic cancer	0.000604	0.0198	CbGeAlD
Mycophenolate mofetil—CYP3A4—Prednisone—hematologic cancer	0.000587	0.00125	CbGbCtD
Mycophenolate mofetil—IMPDH2—testis—hematologic cancer	0.000573	0.0188	CbGeAlD
Mycophenolate mofetil—IMPDH1—testis—hematologic cancer	0.000569	0.0187	CbGeAlD
Mycophenolate mofetil—CYP3A4—Irinotecan—hematologic cancer	0.000557	0.00119	CbGbCtD
Mycophenolate mofetil—CES2—lung—hematologic cancer	0.000552	0.0181	CbGeAlD
Mycophenolate mofetil—UGT1A1—blood—hematologic cancer	0.000535	0.0176	CbGeAlD
Mycophenolate mofetil—CES2—testis—hematologic cancer	0.000521	0.0171	CbGeAlD
Mycophenolate mofetil—UGT2B7—testis—hematologic cancer	0.000521	0.0171	CbGeAlD
Mycophenolate mofetil—CES1—blood—hematologic cancer	0.000519	0.017	CbGeAlD
Mycophenolate mofetil—ABCB1—Doxorubicin—hematologic cancer	0.000508	0.00108	CbGbCtD
Mycophenolate mofetil—CYP3A4—Vinblastine—hematologic cancer	0.000495	0.00106	CbGbCtD
Mycophenolate mofetil—ABCB1—Methotrexate—hematologic cancer	0.000492	0.00105	CbGbCtD
Mycophenolate mofetil—CYP3A4—Vincristine—hematologic cancer	0.000487	0.00104	CbGbCtD
Mycophenolate mofetil—CES1—lung—hematologic cancer	0.000455	0.0149	CbGeAlD
Mycophenolate mofetil—CYP3A4—Etoposide—hematologic cancer	0.000446	0.000951	CbGbCtD
Mycophenolate mofetil—SLCO1B1—blood—hematologic cancer	0.000445	0.0146	CbGeAlD
Mycophenolate mofetil—CES1—testis—hematologic cancer	0.000429	0.0141	CbGeAlD
Mycophenolate mofetil—IMPDH2—lymph node—hematologic cancer	0.000415	0.0136	CbGeAlD
Mycophenolate mofetil—IMPDH1—lymph node—hematologic cancer	0.000413	0.0136	CbGeAlD
Mycophenolate mofetil—CYP2C8—hematopoietic system—hematologic cancer	0.000382	0.0126	CbGeAlD
Mycophenolate mofetil—CES2—lymph node—hematologic cancer	0.000378	0.0124	CbGeAlD
Mycophenolate mofetil—CYP3A4—Dexamethasone—hematologic cancer	0.000367	0.000782	CbGbCtD
Mycophenolate mofetil—CYP3A5—hematopoietic system—hematologic cancer	0.000345	0.0113	CbGeAlD
Mycophenolate mofetil—ABCC2—blood—hematologic cancer	0.000338	0.0111	CbGeAlD
Mycophenolate mofetil—CES1—lymph node—hematologic cancer	0.000311	0.0102	CbGeAlD
Mycophenolate mofetil—CYP3A4—Doxorubicin—hematologic cancer	0.000304	0.000648	CbGbCtD
Mycophenolate mofetil—ALB—testis—hematologic cancer	0.000298	0.0098	CbGeAlD
Mycophenolate mofetil—ABCC2—testis—hematologic cancer	0.000279	0.00918	CbGeAlD
Mycophenolate mofetil—CYP3A4—hematopoietic system—hematologic cancer	0.000259	0.00851	CbGeAlD
Mycophenolate mofetil—CYP2C8—blood—hematologic cancer	0.000253	0.00832	CbGeAlD
Mycophenolate mofetil—ABCG2—blood—hematologic cancer	0.000246	0.00809	CbGeAlD
Mycophenolate mofetil—ABCG2—bone marrow—hematologic cancer	0.000238	0.00783	CbGeAlD
Mycophenolate mofetil—CYP3A5—blood—hematologic cancer	0.000229	0.00751	CbGeAlD
Mycophenolate mofetil—ALB—lymph node—hematologic cancer	0.000216	0.0071	CbGeAlD
Mycophenolate mofetil—ABCG2—lung—hematologic cancer	0.000216	0.00709	CbGeAlD
Mycophenolate mofetil—CYP2C8—testis—hematologic cancer	0.00021	0.00688	CbGeAlD
Mycophenolate mofetil—ABCG2—testis—hematologic cancer	0.000204	0.00669	CbGeAlD
Mycophenolate mofetil—ABCC2—lymph node—hematologic cancer	0.000202	0.00665	CbGeAlD
Mycophenolate mofetil—CYP3A5—lung—hematologic cancer	0.0002	0.00659	CbGeAlD
Mycophenolate mofetil—ABCB1—hematopoietic system—hematologic cancer	0.000183	0.00602	CbGeAlD
Mycophenolate mofetil—CYP3A4—blood—hematologic cancer	0.000172	0.00564	CbGeAlD
Mycophenolate mofetil—ABCG2—lymph node—hematologic cancer	0.000148	0.00485	CbGeAlD
Mycophenolate mofetil—ABCB1—gonad—hematologic cancer	0.000139	0.00458	CbGeAlD
Mycophenolate mofetil—ABCB1—blood—hematologic cancer	0.000121	0.00399	CbGeAlD
Mycophenolate mofetil—ABCB1—bone marrow—hematologic cancer	0.000118	0.00386	CbGeAlD
Mycophenolate mofetil—ABCB1—lung—hematologic cancer	0.000106	0.0035	CbGeAlD
Mycophenolate mofetil—ABCB1—testis—hematologic cancer	0.0001	0.0033	CbGeAlD
Mycophenolate mofetil—ABCB1—lymph node—hematologic cancer	7.28e-05	0.00239	CbGeAlD
Mycophenolate mofetil—Anorexia—Prednisone—hematologic cancer	5.7e-06	3.38e-05	CcSEcCtD
Mycophenolate mofetil—Eye disorder—Doxorubicin—hematologic cancer	5.69e-06	3.38e-05	CcSEcCtD
Mycophenolate mofetil—Ill-defined disorder—Methotrexate—hematologic cancer	5.68e-06	3.37e-05	CcSEcCtD
Mycophenolate mofetil—Tinnitus—Doxorubicin—hematologic cancer	5.67e-06	3.37e-05	CcSEcCtD
Mycophenolate mofetil—Anaemia—Methotrexate—hematologic cancer	5.66e-06	3.36e-05	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Betamethasone—hematologic cancer	5.65e-06	3.36e-05	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Dexamethasone—hematologic cancer	5.65e-06	3.36e-05	CcSEcCtD
Mycophenolate mofetil—Cardiac disorder—Doxorubicin—hematologic cancer	5.65e-06	3.35e-05	CcSEcCtD
Mycophenolate mofetil—Flatulence—Epirubicin—hematologic cancer	5.64e-06	3.35e-05	CcSEcCtD
Mycophenolate mofetil—Tension—Epirubicin—hematologic cancer	5.62e-06	3.34e-05	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Betamethasone—hematologic cancer	5.61e-06	3.33e-05	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Dexamethasone—hematologic cancer	5.61e-06	3.33e-05	CcSEcCtD
Mycophenolate mofetil—Dysgeusia—Epirubicin—hematologic cancer	5.61e-06	3.33e-05	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Triamcinolone—hematologic cancer	5.57e-06	3.31e-05	CcSEcCtD
Mycophenolate mofetil—Nervousness—Epirubicin—hematologic cancer	5.56e-06	3.3e-05	CcSEcCtD
Mycophenolate mofetil—Back pain—Epirubicin—hematologic cancer	5.54e-06	3.29e-05	CcSEcCtD
Mycophenolate mofetil—Angiopathy—Doxorubicin—hematologic cancer	5.52e-06	3.28e-05	CcSEcCtD
Mycophenolate mofetil—Malaise—Methotrexate—hematologic cancer	5.52e-06	3.28e-05	CcSEcCtD
Mycophenolate mofetil—Dizziness—Etoposide—hematologic cancer	5.51e-06	3.27e-05	CcSEcCtD
Mycophenolate mofetil—Muscle spasms—Epirubicin—hematologic cancer	5.51e-06	3.27e-05	CcSEcCtD
Mycophenolate mofetil—Vertigo—Methotrexate—hematologic cancer	5.5e-06	3.26e-05	CcSEcCtD
Mycophenolate mofetil—Mediastinal disorder—Doxorubicin—hematologic cancer	5.49e-06	3.26e-05	CcSEcCtD
Mycophenolate mofetil—Leukopenia—Methotrexate—hematologic cancer	5.48e-06	3.25e-05	CcSEcCtD
Mycophenolate mofetil—Chills—Doxorubicin—hematologic cancer	5.46e-06	3.24e-05	CcSEcCtD
Mycophenolate mofetil—Urticaria—Dexamethasone—hematologic cancer	5.45e-06	3.24e-05	CcSEcCtD
Mycophenolate mofetil—Urticaria—Betamethasone—hematologic cancer	5.45e-06	3.24e-05	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Prednisone—hematologic cancer	5.44e-06	3.23e-05	CcSEcCtD
Mycophenolate mofetil—Dizziness—Prednisolone—hematologic cancer	5.44e-06	3.23e-05	CcSEcCtD
Mycophenolate mofetil—Arrhythmia—Doxorubicin—hematologic cancer	5.44e-06	3.23e-05	CcSEcCtD
Mycophenolate mofetil—Asthenia—Triamcinolone—hematologic cancer	5.43e-06	3.22e-05	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Betamethasone—hematologic cancer	5.42e-06	3.22e-05	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Dexamethasone—hematologic cancer	5.42e-06	3.22e-05	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Betamethasone—hematologic cancer	5.42e-06	3.22e-05	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Dexamethasone—hematologic cancer	5.42e-06	3.22e-05	CcSEcCtD
Mycophenolate mofetil—Nausea—Cisplatin—hematologic cancer	5.41e-06	3.21e-05	CcSEcCtD
Mycophenolate mofetil—Insomnia—Prednisone—hematologic cancer	5.4e-06	3.21e-05	CcSEcCtD
Mycophenolate mofetil—Alopecia—Doxorubicin—hematologic cancer	5.38e-06	3.19e-05	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Prednisone—hematologic cancer	5.37e-06	3.19e-05	CcSEcCtD
Mycophenolate mofetil—Pruritus—Triamcinolone—hematologic cancer	5.35e-06	3.18e-05	CcSEcCtD
Mycophenolate mofetil—Cough—Methotrexate—hematologic cancer	5.34e-06	3.17e-05	CcSEcCtD
Mycophenolate mofetil—Mental disorder—Doxorubicin—hematologic cancer	5.33e-06	3.17e-05	CcSEcCtD
Mycophenolate mofetil—Ill-defined disorder—Epirubicin—hematologic cancer	5.31e-06	3.15e-05	CcSEcCtD
Mycophenolate mofetil—Convulsion—Methotrexate—hematologic cancer	5.3e-06	3.15e-05	CcSEcCtD
Mycophenolate mofetil—Vomiting—Etoposide—hematologic cancer	5.3e-06	3.15e-05	CcSEcCtD
Mycophenolate mofetil—Malnutrition—Doxorubicin—hematologic cancer	5.3e-06	3.15e-05	CcSEcCtD
Mycophenolate mofetil—Anaemia—Epirubicin—hematologic cancer	5.29e-06	3.14e-05	CcSEcCtD
Mycophenolate mofetil—Agitation—Epirubicin—hematologic cancer	5.26e-06	3.12e-05	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Prednisone—hematologic cancer	5.26e-06	3.12e-05	CcSEcCtD
Mycophenolate mofetil—Rash—Etoposide—hematologic cancer	5.26e-06	3.12e-05	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Etoposide—hematologic cancer	5.25e-06	3.12e-05	CcSEcCtD
Mycophenolate mofetil—Headache—Etoposide—hematologic cancer	5.22e-06	3.1e-05	CcSEcCtD
Mycophenolate mofetil—Flatulence—Doxorubicin—hematologic cancer	5.22e-06	3.1e-05	CcSEcCtD
Mycophenolate mofetil—Arthralgia—Methotrexate—hematologic cancer	5.21e-06	3.09e-05	CcSEcCtD
Mycophenolate mofetil—Chest pain—Methotrexate—hematologic cancer	5.21e-06	3.09e-05	CcSEcCtD
Mycophenolate mofetil—Myalgia—Methotrexate—hematologic cancer	5.21e-06	3.09e-05	CcSEcCtD
Mycophenolate mofetil—Tension—Doxorubicin—hematologic cancer	5.2e-06	3.09e-05	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Prednisone—hematologic cancer	5.19e-06	3.08e-05	CcSEcCtD
Mycophenolate mofetil—Dysgeusia—Doxorubicin—hematologic cancer	5.19e-06	3.08e-05	CcSEcCtD
Mycophenolate mofetil—Rash—Prednisolone—hematologic cancer	5.18e-06	3.08e-05	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Prednisolone—hematologic cancer	5.18e-06	3.08e-05	CcSEcCtD
Mycophenolate mofetil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	5.17e-06	3.07e-05	CcSEcCtD
Mycophenolate mofetil—Malaise—Epirubicin—hematologic cancer	5.16e-06	3.07e-05	CcSEcCtD
Mycophenolate mofetil—Headache—Prednisolone—hematologic cancer	5.15e-06	3.06e-05	CcSEcCtD
Mycophenolate mofetil—Discomfort—Methotrexate—hematologic cancer	5.15e-06	3.06e-05	CcSEcCtD
Mycophenolate mofetil—Nervousness—Doxorubicin—hematologic cancer	5.15e-06	3.06e-05	CcSEcCtD
Mycophenolate mofetil—Vertigo—Epirubicin—hematologic cancer	5.14e-06	3.05e-05	CcSEcCtD
Mycophenolate mofetil—Syncope—Epirubicin—hematologic cancer	5.14e-06	3.05e-05	CcSEcCtD
Mycophenolate mofetil—Leukopenia—Epirubicin—hematologic cancer	5.13e-06	3.04e-05	CcSEcCtD
Mycophenolate mofetil—Back pain—Doxorubicin—hematologic cancer	5.13e-06	3.04e-05	CcSEcCtD
Mycophenolate mofetil—Constipation—Prednisone—hematologic cancer	5.11e-06	3.03e-05	CcSEcCtD
Mycophenolate mofetil—Muscle spasms—Doxorubicin—hematologic cancer	5.09e-06	3.02e-05	CcSEcCtD
Mycophenolate mofetil—Palpitations—Epirubicin—hematologic cancer	5.06e-06	3e-05	CcSEcCtD
Mycophenolate mofetil—Confusional state—Methotrexate—hematologic cancer	5.04e-06	2.99e-05	CcSEcCtD
Mycophenolate mofetil—Loss of consciousness—Epirubicin—hematologic cancer	5.03e-06	2.99e-05	CcSEcCtD
Mycophenolate mofetil—Dizziness—Triamcinolone—hematologic cancer	5e-06	2.97e-05	CcSEcCtD
Mycophenolate mofetil—Cough—Epirubicin—hematologic cancer	5e-06	2.97e-05	CcSEcCtD
Mycophenolate mofetil—Anaphylactic shock—Methotrexate—hematologic cancer	4.99e-06	2.97e-05	CcSEcCtD
Mycophenolate mofetil—Convulsion—Epirubicin—hematologic cancer	4.96e-06	2.95e-05	CcSEcCtD
Mycophenolate mofetil—Infection—Methotrexate—hematologic cancer	4.96e-06	2.95e-05	CcSEcCtD
Mycophenolate mofetil—Nausea—Etoposide—hematologic cancer	4.95e-06	2.94e-05	CcSEcCtD
Mycophenolate mofetil—Hypertension—Epirubicin—hematologic cancer	4.94e-06	2.94e-05	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Prednisone—hematologic cancer	4.92e-06	2.92e-05	CcSEcCtD
Mycophenolate mofetil—Asthenia—Betamethasone—hematologic cancer	4.92e-06	2.92e-05	CcSEcCtD
Mycophenolate mofetil—Asthenia—Dexamethasone—hematologic cancer	4.92e-06	2.92e-05	CcSEcCtD
Mycophenolate mofetil—Ill-defined disorder—Doxorubicin—hematologic cancer	4.92e-06	2.92e-05	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Methotrexate—hematologic cancer	4.9e-06	2.91e-05	CcSEcCtD
Mycophenolate mofetil—Anaemia—Doxorubicin—hematologic cancer	4.9e-06	2.91e-05	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Methotrexate—hematologic cancer	4.89e-06	2.9e-05	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Prednisone—hematologic cancer	4.89e-06	2.9e-05	CcSEcCtD
Mycophenolate mofetil—Nausea—Prednisolone—hematologic cancer	4.88e-06	2.9e-05	CcSEcCtD
Mycophenolate mofetil—Myalgia—Epirubicin—hematologic cancer	4.88e-06	2.89e-05	CcSEcCtD
Mycophenolate mofetil—Chest pain—Epirubicin—hematologic cancer	4.88e-06	2.89e-05	CcSEcCtD
Mycophenolate mofetil—Arthralgia—Epirubicin—hematologic cancer	4.88e-06	2.89e-05	CcSEcCtD
Mycophenolate mofetil—Agitation—Doxorubicin—hematologic cancer	4.87e-06	2.89e-05	CcSEcCtD
Mycophenolate mofetil—Anxiety—Epirubicin—hematologic cancer	4.86e-06	2.88e-05	CcSEcCtD
Mycophenolate mofetil—Pruritus—Betamethasone—hematologic cancer	4.85e-06	2.88e-05	CcSEcCtD
Mycophenolate mofetil—Pruritus—Dexamethasone—hematologic cancer	4.85e-06	2.88e-05	CcSEcCtD
Mycophenolate mofetil—Skin disorder—Methotrexate—hematologic cancer	4.85e-06	2.88e-05	CcSEcCtD
Mycophenolate mofetil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	4.84e-06	2.87e-05	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Methotrexate—hematologic cancer	4.83e-06	2.87e-05	CcSEcCtD
Mycophenolate mofetil—Discomfort—Epirubicin—hematologic cancer	4.82e-06	2.86e-05	CcSEcCtD
Mycophenolate mofetil—Vomiting—Triamcinolone—hematologic cancer	4.81e-06	2.85e-05	CcSEcCtD
Mycophenolate mofetil—Malaise—Doxorubicin—hematologic cancer	4.78e-06	2.84e-05	CcSEcCtD
Mycophenolate mofetil—Rash—Triamcinolone—hematologic cancer	4.77e-06	2.83e-05	CcSEcCtD
Mycophenolate mofetil—Dry mouth—Epirubicin—hematologic cancer	4.77e-06	2.83e-05	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Triamcinolone—hematologic cancer	4.76e-06	2.83e-05	CcSEcCtD
Mycophenolate mofetil—Vertigo—Doxorubicin—hematologic cancer	4.76e-06	2.83e-05	CcSEcCtD
Mycophenolate mofetil—Anorexia—Methotrexate—hematologic cancer	4.76e-06	2.83e-05	CcSEcCtD
Mycophenolate mofetil—Syncope—Doxorubicin—hematologic cancer	4.75e-06	2.82e-05	CcSEcCtD
Mycophenolate mofetil—Urticaria—Prednisone—hematologic cancer	4.75e-06	2.82e-05	CcSEcCtD
Mycophenolate mofetil—Leukopenia—Doxorubicin—hematologic cancer	4.74e-06	2.82e-05	CcSEcCtD
Mycophenolate mofetil—Headache—Triamcinolone—hematologic cancer	4.74e-06	2.81e-05	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Prednisone—hematologic cancer	4.72e-06	2.8e-05	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Prednisone—hematologic cancer	4.72e-06	2.8e-05	CcSEcCtD
Mycophenolate mofetil—Confusional state—Epirubicin—hematologic cancer	4.71e-06	2.8e-05	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Betamethasone—hematologic cancer	4.69e-06	2.79e-05	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Dexamethasone—hematologic cancer	4.69e-06	2.79e-05	CcSEcCtD
Mycophenolate mofetil—Palpitations—Doxorubicin—hematologic cancer	4.68e-06	2.78e-05	CcSEcCtD
Mycophenolate mofetil—Anaphylactic shock—Epirubicin—hematologic cancer	4.67e-06	2.78e-05	CcSEcCtD
Mycophenolate mofetil—Oedema—Epirubicin—hematologic cancer	4.67e-06	2.78e-05	CcSEcCtD
Mycophenolate mofetil—Hypotension—Methotrexate—hematologic cancer	4.67e-06	2.77e-05	CcSEcCtD
Mycophenolate mofetil—Loss of consciousness—Doxorubicin—hematologic cancer	4.66e-06	2.77e-05	CcSEcCtD
Mycophenolate mofetil—Infection—Epirubicin—hematologic cancer	4.64e-06	2.76e-05	CcSEcCtD
Mycophenolate mofetil—Cough—Doxorubicin—hematologic cancer	4.62e-06	2.75e-05	CcSEcCtD
Mycophenolate mofetil—Shock—Epirubicin—hematologic cancer	4.6e-06	2.73e-05	CcSEcCtD
Mycophenolate mofetil—Convulsion—Doxorubicin—hematologic cancer	4.59e-06	2.73e-05	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Epirubicin—hematologic cancer	4.58e-06	2.72e-05	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Epirubicin—hematologic cancer	4.58e-06	2.72e-05	CcSEcCtD
Mycophenolate mofetil—Hypertension—Doxorubicin—hematologic cancer	4.57e-06	2.72e-05	CcSEcCtD
Mycophenolate mofetil—Tachycardia—Epirubicin—hematologic cancer	4.56e-06	2.71e-05	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Methotrexate—hematologic cancer	4.55e-06	2.7e-05	CcSEcCtD
Mycophenolate mofetil—Skin disorder—Epirubicin—hematologic cancer	4.54e-06	2.7e-05	CcSEcCtD
Mycophenolate mofetil—Dizziness—Dexamethasone—hematologic cancer	4.54e-06	2.69e-05	CcSEcCtD
Mycophenolate mofetil—Dizziness—Betamethasone—hematologic cancer	4.54e-06	2.69e-05	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Epirubicin—hematologic cancer	4.52e-06	2.68e-05	CcSEcCtD
Mycophenolate mofetil—Insomnia—Methotrexate—hematologic cancer	4.52e-06	2.68e-05	CcSEcCtD
Mycophenolate mofetil—Chest pain—Doxorubicin—hematologic cancer	4.51e-06	2.68e-05	CcSEcCtD
Mycophenolate mofetil—Arthralgia—Doxorubicin—hematologic cancer	4.51e-06	2.68e-05	CcSEcCtD
Mycophenolate mofetil—Myalgia—Doxorubicin—hematologic cancer	4.51e-06	2.68e-05	CcSEcCtD
Mycophenolate mofetil—Anxiety—Doxorubicin—hematologic cancer	4.5e-06	2.67e-05	CcSEcCtD
Mycophenolate mofetil—Nausea—Triamcinolone—hematologic cancer	4.49e-06	2.67e-05	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Methotrexate—hematologic cancer	4.48e-06	2.66e-05	CcSEcCtD
Mycophenolate mofetil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	4.48e-06	2.66e-05	CcSEcCtD
Mycophenolate mofetil—Discomfort—Doxorubicin—hematologic cancer	4.46e-06	2.65e-05	CcSEcCtD
Mycophenolate mofetil—Anorexia—Epirubicin—hematologic cancer	4.45e-06	2.65e-05	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Methotrexate—hematologic cancer	4.45e-06	2.64e-05	CcSEcCtD
Mycophenolate mofetil—Somnolence—Methotrexate—hematologic cancer	4.44e-06	2.64e-05	CcSEcCtD
Mycophenolate mofetil—Dry mouth—Doxorubicin—hematologic cancer	4.41e-06	2.62e-05	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Prednisone—hematologic cancer	4.4e-06	2.61e-05	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Methotrexate—hematologic cancer	4.4e-06	2.61e-05	CcSEcCtD
Mycophenolate mofetil—Hypotension—Epirubicin—hematologic cancer	4.37e-06	2.59e-05	CcSEcCtD
Mycophenolate mofetil—Vomiting—Betamethasone—hematologic cancer	4.36e-06	2.59e-05	CcSEcCtD
Mycophenolate mofetil—Vomiting—Dexamethasone—hematologic cancer	4.36e-06	2.59e-05	CcSEcCtD
Mycophenolate mofetil—Confusional state—Doxorubicin—hematologic cancer	4.36e-06	2.59e-05	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Methotrexate—hematologic cancer	4.34e-06	2.58e-05	CcSEcCtD
Mycophenolate mofetil—Rash—Betamethasone—hematologic cancer	4.33e-06	2.57e-05	CcSEcCtD
Mycophenolate mofetil—Rash—Dexamethasone—hematologic cancer	4.33e-06	2.57e-05	CcSEcCtD
Mycophenolate mofetil—Anaphylactic shock—Doxorubicin—hematologic cancer	4.32e-06	2.57e-05	CcSEcCtD
Mycophenolate mofetil—Oedema—Doxorubicin—hematologic cancer	4.32e-06	2.57e-05	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Betamethasone—hematologic cancer	4.32e-06	2.57e-05	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Dexamethasone—hematologic cancer	4.32e-06	2.57e-05	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Methotrexate—hematologic cancer	4.31e-06	2.56e-05	CcSEcCtD
Mycophenolate mofetil—Headache—Dexamethasone—hematologic cancer	4.3e-06	2.55e-05	CcSEcCtD
Mycophenolate mofetil—Headache—Betamethasone—hematologic cancer	4.3e-06	2.55e-05	CcSEcCtD
Mycophenolate mofetil—Infection—Doxorubicin—hematologic cancer	4.3e-06	2.55e-05	CcSEcCtD
Mycophenolate mofetil—Asthenia—Prednisone—hematologic cancer	4.29e-06	2.55e-05	CcSEcCtD
Mycophenolate mofetil—Pain—Methotrexate—hematologic cancer	4.27e-06	2.54e-05	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Epirubicin—hematologic cancer	4.26e-06	2.53e-05	CcSEcCtD
Mycophenolate mofetil—Shock—Doxorubicin—hematologic cancer	4.25e-06	2.53e-05	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Doxorubicin—hematologic cancer	4.24e-06	2.52e-05	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Doxorubicin—hematologic cancer	4.23e-06	2.51e-05	CcSEcCtD
Mycophenolate mofetil—Pruritus—Prednisone—hematologic cancer	4.23e-06	2.51e-05	CcSEcCtD
Mycophenolate mofetil—Insomnia—Epirubicin—hematologic cancer	4.23e-06	2.51e-05	CcSEcCtD
Mycophenolate mofetil—Tachycardia—Doxorubicin—hematologic cancer	4.22e-06	2.51e-05	CcSEcCtD
Mycophenolate mofetil—Skin disorder—Doxorubicin—hematologic cancer	4.2e-06	2.49e-05	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Epirubicin—hematologic cancer	4.2e-06	2.49e-05	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Doxorubicin—hematologic cancer	4.18e-06	2.48e-05	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Epirubicin—hematologic cancer	4.17e-06	2.47e-05	CcSEcCtD
Mycophenolate mofetil—Somnolence—Epirubicin—hematologic cancer	4.15e-06	2.47e-05	CcSEcCtD
Mycophenolate mofetil—Anorexia—Doxorubicin—hematologic cancer	4.12e-06	2.45e-05	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Methotrexate—hematologic cancer	4.12e-06	2.44e-05	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Epirubicin—hematologic cancer	4.11e-06	2.44e-05	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Prednisone—hematologic cancer	4.09e-06	2.43e-05	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Methotrexate—hematologic cancer	4.08e-06	2.42e-05	CcSEcCtD
Mycophenolate mofetil—Nausea—Dexamethasone—hematologic cancer	4.08e-06	2.42e-05	CcSEcCtD
Mycophenolate mofetil—Nausea—Betamethasone—hematologic cancer	4.08e-06	2.42e-05	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Epirubicin—hematologic cancer	4.06e-06	2.41e-05	CcSEcCtD
Mycophenolate mofetil—Hypotension—Doxorubicin—hematologic cancer	4.04e-06	2.4e-05	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Epirubicin—hematologic cancer	4.03e-06	2.4e-05	CcSEcCtD
Mycophenolate mofetil—Pain—Epirubicin—hematologic cancer	4e-06	2.37e-05	CcSEcCtD
Mycophenolate mofetil—Constipation—Epirubicin—hematologic cancer	4e-06	2.37e-05	CcSEcCtD
Mycophenolate mofetil—Urticaria—Methotrexate—hematologic cancer	3.97e-06	2.36e-05	CcSEcCtD
Mycophenolate mofetil—Dizziness—Prednisone—hematologic cancer	3.95e-06	2.35e-05	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Methotrexate—hematologic cancer	3.95e-06	2.34e-05	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Methotrexate—hematologic cancer	3.95e-06	2.34e-05	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	3.94e-06	2.34e-05	CcSEcCtD
Mycophenolate mofetil—Insomnia—Doxorubicin—hematologic cancer	3.91e-06	2.32e-05	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Doxorubicin—hematologic cancer	3.88e-06	2.31e-05	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Doxorubicin—hematologic cancer	3.86e-06	2.29e-05	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Epirubicin—hematologic cancer	3.85e-06	2.29e-05	CcSEcCtD
Mycophenolate mofetil—Somnolence—Doxorubicin—hematologic cancer	3.84e-06	2.28e-05	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Epirubicin—hematologic cancer	3.82e-06	2.27e-05	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Doxorubicin—hematologic cancer	3.81e-06	2.26e-05	CcSEcCtD
Mycophenolate mofetil—Vomiting—Prednisone—hematologic cancer	3.8e-06	2.26e-05	CcSEcCtD
Mycophenolate mofetil—Rash—Prednisone—hematologic cancer	3.77e-06	2.24e-05	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Prednisone—hematologic cancer	3.76e-06	2.24e-05	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Doxorubicin—hematologic cancer	3.76e-06	2.23e-05	CcSEcCtD
Mycophenolate mofetil—Headache—Prednisone—hematologic cancer	3.74e-06	2.22e-05	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Doxorubicin—hematologic cancer	3.73e-06	2.22e-05	CcSEcCtD
Mycophenolate mofetil—Urticaria—Epirubicin—hematologic cancer	3.71e-06	2.2e-05	CcSEcCtD
Mycophenolate mofetil—Pain—Doxorubicin—hematologic cancer	3.7e-06	2.2e-05	CcSEcCtD
Mycophenolate mofetil—Constipation—Doxorubicin—hematologic cancer	3.7e-06	2.2e-05	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Epirubicin—hematologic cancer	3.69e-06	2.19e-05	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Epirubicin—hematologic cancer	3.69e-06	2.19e-05	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Methotrexate—hematologic cancer	3.68e-06	2.18e-05	CcSEcCtD
Mycophenolate mofetil—Asthenia—Methotrexate—hematologic cancer	3.58e-06	2.13e-05	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Doxorubicin—hematologic cancer	3.56e-06	2.12e-05	CcSEcCtD
Mycophenolate mofetil—Nausea—Prednisone—hematologic cancer	3.55e-06	2.11e-05	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Doxorubicin—hematologic cancer	3.54e-06	2.1e-05	CcSEcCtD
Mycophenolate mofetil—Pruritus—Methotrexate—hematologic cancer	3.53e-06	2.1e-05	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Epirubicin—hematologic cancer	3.44e-06	2.04e-05	CcSEcCtD
Mycophenolate mofetil—Urticaria—Doxorubicin—hematologic cancer	3.44e-06	2.04e-05	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Doxorubicin—hematologic cancer	3.42e-06	2.03e-05	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Doxorubicin—hematologic cancer	3.42e-06	2.03e-05	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Methotrexate—hematologic cancer	3.42e-06	2.03e-05	CcSEcCtD
Mycophenolate mofetil—Asthenia—Epirubicin—hematologic cancer	3.35e-06	1.99e-05	CcSEcCtD
Mycophenolate mofetil—Pruritus—Epirubicin—hematologic cancer	3.31e-06	1.96e-05	CcSEcCtD
Mycophenolate mofetil—Dizziness—Methotrexate—hematologic cancer	3.3e-06	1.96e-05	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Epirubicin—hematologic cancer	3.2e-06	1.9e-05	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Doxorubicin—hematologic cancer	3.19e-06	1.89e-05	CcSEcCtD
Mycophenolate mofetil—Vomiting—Methotrexate—hematologic cancer	3.18e-06	1.89e-05	CcSEcCtD
Mycophenolate mofetil—Rash—Methotrexate—hematologic cancer	3.15e-06	1.87e-05	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Methotrexate—hematologic cancer	3.15e-06	1.87e-05	CcSEcCtD
Mycophenolate mofetil—Headache—Methotrexate—hematologic cancer	3.13e-06	1.86e-05	CcSEcCtD
Mycophenolate mofetil—Asthenia—Doxorubicin—hematologic cancer	3.1e-06	1.84e-05	CcSEcCtD
Mycophenolate mofetil—Dizziness—Epirubicin—hematologic cancer	3.09e-06	1.84e-05	CcSEcCtD
Mycophenolate mofetil—Pruritus—Doxorubicin—hematologic cancer	3.06e-06	1.82e-05	CcSEcCtD
Mycophenolate mofetil—Vomiting—Epirubicin—hematologic cancer	2.97e-06	1.76e-05	CcSEcCtD
Mycophenolate mofetil—Nausea—Methotrexate—hematologic cancer	2.97e-06	1.76e-05	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Doxorubicin—hematologic cancer	2.96e-06	1.76e-05	CcSEcCtD
Mycophenolate mofetil—Rash—Epirubicin—hematologic cancer	2.95e-06	1.75e-05	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Epirubicin—hematologic cancer	2.94e-06	1.75e-05	CcSEcCtD
Mycophenolate mofetil—Headache—Epirubicin—hematologic cancer	2.93e-06	1.74e-05	CcSEcCtD
Mycophenolate mofetil—Dizziness—Doxorubicin—hematologic cancer	2.86e-06	1.7e-05	CcSEcCtD
Mycophenolate mofetil—Nausea—Epirubicin—hematologic cancer	2.78e-06	1.65e-05	CcSEcCtD
Mycophenolate mofetil—Vomiting—Doxorubicin—hematologic cancer	2.75e-06	1.63e-05	CcSEcCtD
Mycophenolate mofetil—Rash—Doxorubicin—hematologic cancer	2.73e-06	1.62e-05	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Doxorubicin—hematologic cancer	2.72e-06	1.62e-05	CcSEcCtD
Mycophenolate mofetil—Headache—Doxorubicin—hematologic cancer	2.71e-06	1.61e-05	CcSEcCtD
Mycophenolate mofetil—Nausea—Doxorubicin—hematologic cancer	2.57e-06	1.53e-05	CcSEcCtD
Mycophenolate mofetil—SLCO1B3—Metabolism—ALB—hematologic cancer	2.12e-06	2.82e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	2.11e-06	2.82e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A8—Metabolism—AKT1—hematologic cancer	2.11e-06	2.81e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—ABCB1—hematologic cancer	2.1e-06	2.8e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—UGT1A1—hematologic cancer	2.1e-06	2.8e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	2.1e-06	2.8e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—MTR—hematologic cancer	2.09e-06	2.79e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—ABCG2—hematologic cancer	2.09e-06	2.79e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Platelet activation, signaling and aggregation—PIK3CA—hematologic cancer	2.09e-06	2.79e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—ABCG2—hematologic cancer	2.08e-06	2.77e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—MTR—hematologic cancer	2.08e-06	2.77e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	2.06e-06	2.74e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—ENO2—hematologic cancer	2.05e-06	2.73e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—SLC22A1—hematologic cancer	2.05e-06	2.73e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—CRABP1—hematologic cancer	2.05e-06	2.73e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—GSTM1—hematologic cancer	2.04e-06	2.72e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—NCOR1—hematologic cancer	2.04e-06	2.72e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—ENO2—hematologic cancer	2.04e-06	2.72e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—CREBBP—hematologic cancer	2.04e-06	2.72e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—PIK3CD—hematologic cancer	2.03e-06	2.7e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—PIK3R1—hematologic cancer	2.02e-06	2.7e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—ALOX5—hematologic cancer	1.99e-06	2.66e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	1.99e-06	2.66e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—GSTT1—hematologic cancer	1.99e-06	2.65e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—GSTT1—hematologic cancer	1.98e-06	2.64e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.96e-06	2.61e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—MTAP—hematologic cancer	1.96e-06	2.61e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—MTHFR—hematologic cancer	1.95e-06	2.6e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.95e-06	2.6e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—SDC1—hematologic cancer	1.95e-06	2.59e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—SDC1—hematologic cancer	1.93e-06	2.58e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—PIK3CD—hematologic cancer	1.93e-06	2.58e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—NUP98—hematologic cancer	1.93e-06	2.57e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—PIK3R1—hematologic cancer	1.92e-06	2.55e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—CD44—hematologic cancer	1.91e-06	2.54e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—NQO1—hematologic cancer	1.91e-06	2.54e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—ALB—hematologic cancer	1.91e-06	2.54e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Metabolism—PIK3CA—hematologic cancer	1.88e-06	2.51e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.88e-06	2.5e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—ADCY7—hematologic cancer	1.87e-06	2.5e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—NCOA3—hematologic cancer	1.87e-06	2.5e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—PIK3CB—hematologic cancer	1.87e-06	2.49e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—JAK2—hematologic cancer	1.86e-06	2.48e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—NUP214—hematologic cancer	1.86e-06	2.48e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.86e-06	2.48e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.85e-06	2.47e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.85e-06	2.46e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.83e-06	2.44e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—PIK3R1—hematologic cancer	1.83e-06	2.43e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—ABCG2—hematologic cancer	1.82e-06	2.43e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—MTR—hematologic cancer	1.82e-06	2.43e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—CYCS—hematologic cancer	1.81e-06	2.41e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—MTHFR—hematologic cancer	1.81e-06	2.41e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—HSP90AA1—hematologic cancer	1.8e-06	2.39e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—PIK3CG—hematologic cancer	1.79e-06	2.38e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—ENO2—hematologic cancer	1.79e-06	2.38e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—PIK3CG—hematologic cancer	1.79e-06	2.38e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—PIK3CB—hematologic cancer	1.77e-06	2.36e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.75e-06	2.34e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.74e-06	2.32e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—FHL2—hematologic cancer	1.74e-06	2.32e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—GSTT1—hematologic cancer	1.73e-06	2.31e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.72e-06	2.29e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—AGRN—hematologic cancer	1.71e-06	2.28e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Platelet activation, signaling and aggregation—AKT1—hematologic cancer	1.71e-06	2.28e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—SDC1—hematologic cancer	1.69e-06	2.26e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—PIK3CB—hematologic cancer	1.69e-06	2.25e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	1.68e-06	2.24e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—CREBBP—hematologic cancer	1.66e-06	2.21e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—CREBBP—hematologic cancer	1.66e-06	2.21e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—NQO1—hematologic cancer	1.65e-06	2.2e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—CD44—hematologic cancer	1.65e-06	2.2e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—NQO1—hematologic cancer	1.64e-06	2.19e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—CD44—hematologic cancer	1.64e-06	2.19e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—PIK3CG—hematologic cancer	1.64e-06	2.18e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—IL2—hematologic cancer	1.62e-06	2.16e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.62e-06	2.16e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—HMMR—hematologic cancer	1.62e-06	2.16e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—IDH2—hematologic cancer	1.62e-06	2.16e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.62e-06	2.16e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—PTEN—hematologic cancer	1.61e-06	2.15e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.61e-06	2.15e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—GSTP1—hematologic cancer	1.59e-06	2.12e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—PIK3CD—hematologic cancer	1.57e-06	2.09e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—PIK3CD—hematologic cancer	1.57e-06	2.09e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—CYCS—hematologic cancer	1.57e-06	2.09e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—CYCS—hematologic cancer	1.56e-06	2.07e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—HSP90AA1—hematologic cancer	1.56e-06	2.07e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—ALB—hematologic cancer	1.55e-06	2.07e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—ALB—hematologic cancer	1.55e-06	2.07e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—HSP90AA1—hematologic cancer	1.55e-06	2.06e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—EP300—hematologic cancer	1.54e-06	2.05e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Metabolism—AKT1—hematologic cancer	1.54e-06	2.05e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—ARNTL—hematologic cancer	1.52e-06	2.03e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	1.52e-06	2.02e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—CREBBP—hematologic cancer	1.52e-06	2.02e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—PIK3CG—hematologic cancer	1.52e-06	2.02e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—ABCB1—hematologic cancer	1.51e-06	2.01e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—PIK3R1—hematologic cancer	1.48e-06	1.98e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—PIK3R1—hematologic cancer	1.48e-06	1.98e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—CA9—hematologic cancer	1.48e-06	1.97e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—ACP5—hematologic cancer	1.48e-06	1.97e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—NCOR1—hematologic cancer	1.46e-06	1.95e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—GSTM1—hematologic cancer	1.46e-06	1.95e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—NCOR2—hematologic cancer	1.46e-06	1.95e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—EP300—hematologic cancer	1.46e-06	1.94e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—PTEN—hematologic cancer	1.46e-06	1.94e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—CD44—hematologic cancer	1.44e-06	1.92e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—NQO1—hematologic cancer	1.44e-06	1.92e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—PIK3CD—hematologic cancer	1.44e-06	1.92e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—ALB—hematologic cancer	1.42e-06	1.89e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—SRC—hematologic cancer	1.42e-06	1.89e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—CREBBP—hematologic cancer	1.41e-06	1.87e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.4e-06	1.86e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—IDH1—hematologic cancer	1.39e-06	1.86e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.39e-06	1.85e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—EP300—hematologic cancer	1.39e-06	1.85e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—VEGFA—hematologic cancer	1.38e-06	1.84e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—GSTP1—hematologic cancer	1.38e-06	1.84e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—GSTO1—hematologic cancer	1.38e-06	1.84e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—ABCC3—hematologic cancer	1.38e-06	1.84e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—TXN—hematologic cancer	1.38e-06	1.84e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—GSTP1—hematologic cancer	1.37e-06	1.83e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—PIK3CB—hematologic cancer	1.37e-06	1.83e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—PIK3CB—hematologic cancer	1.37e-06	1.83e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—NRAS—hematologic cancer	1.36e-06	1.82e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—CYCS—hematologic cancer	1.36e-06	1.82e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—PIK3R1—hematologic cancer	1.36e-06	1.81e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—HSP90AA1—hematologic cancer	1.36e-06	1.81e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—SPHK1—hematologic cancer	1.35e-06	1.8e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.33e-06	1.78e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—PIK3CD—hematologic cancer	1.33e-06	1.78e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.33e-06	1.77e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—ALB—hematologic cancer	1.32e-06	1.75e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—MAPK3—hematologic cancer	1.31e-06	1.74e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—ABCB1—hematologic cancer	1.31e-06	1.74e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—ABCB1—hematologic cancer	1.3e-06	1.73e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—UGT1A1—hematologic cancer	1.3e-06	1.73e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—MTHFR—hematologic cancer	1.29e-06	1.72e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—GSTM1—hematologic cancer	1.27e-06	1.69e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—NCOR1—hematologic cancer	1.27e-06	1.69e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—TGFB1—hematologic cancer	1.27e-06	1.69e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—GSTM1—hematologic cancer	1.26e-06	1.68e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—NCOR1—hematologic cancer	1.26e-06	1.68e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—CRABP1—hematologic cancer	1.26e-06	1.68e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—SLC22A1—hematologic cancer	1.26e-06	1.68e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—PIK3R1—hematologic cancer	1.26e-06	1.68e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—PIK3CB—hematologic cancer	1.26e-06	1.67e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—ALOX5—hematologic cancer	1.23e-06	1.64e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—GSTP1—hematologic cancer	1.2e-06	1.6e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—NUP98—hematologic cancer	1.19e-06	1.58e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—PTEN—hematologic cancer	1.18e-06	1.58e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—PTEN—hematologic cancer	1.18e-06	1.58e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—KRAS—hematologic cancer	1.17e-06	1.56e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—PIK3CB—hematologic cancer	1.16e-06	1.55e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—NCOA3—hematologic cancer	1.15e-06	1.54e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—ADCY7—hematologic cancer	1.15e-06	1.54e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—NUP214—hematologic cancer	1.15e-06	1.53e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—PIK3CA—hematologic cancer	1.14e-06	1.52e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—EP300—hematologic cancer	1.13e-06	1.5e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—EP300—hematologic cancer	1.13e-06	1.5e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—MTR—hematologic cancer	1.12e-06	1.5e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—ABCG2—hematologic cancer	1.12e-06	1.5e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—MTHFR—hematologic cancer	1.12e-06	1.49e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—MTHFR—hematologic cancer	1.11e-06	1.48e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—GSTM1—hematologic cancer	1.1e-06	1.47e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—NCOR1—hematologic cancer	1.1e-06	1.47e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—ENO2—hematologic cancer	1.1e-06	1.47e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—PIK3CG—hematologic cancer	1.09e-06	1.45e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—PTEN—hematologic cancer	1.08e-06	1.45e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—PIK3CA—hematologic cancer	1.08e-06	1.44e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—GSTT1—hematologic cancer	1.07e-06	1.42e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—SDC1—hematologic cancer	1.04e-06	1.39e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—TP53—hematologic cancer	1.04e-06	1.39e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—EP300—hematologic cancer	1.03e-06	1.38e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—PIK3CA—hematologic cancer	1.03e-06	1.37e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—CREBBP—hematologic cancer	1.01e-06	1.34e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—PTEN—hematologic cancer	1e-06	1.34e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—HRAS—hematologic cancer	9.98e-07	1.33e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	9.87e-07	1.32e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	9.82e-07	1.31e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—MTHFR—hematologic cancer	9.76e-07	1.3e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—EP300—hematologic cancer	9.58e-07	1.28e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—PIK3CD—hematologic cancer	9.56e-07	1.27e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—ALB—hematologic cancer	9.43e-07	1.26e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—PIK3CG—hematologic cancer	9.41e-07	1.25e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—PIK3CG—hematologic cancer	9.36e-07	1.25e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—AKT1—hematologic cancer	9.31e-07	1.24e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—PIK3R1—hematologic cancer	9.02e-07	1.2e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—CD44—hematologic cancer	8.88e-07	1.18e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—NQO1—hematologic cancer	8.88e-07	1.18e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—AKT1—hematologic cancer	8.81e-07	1.17e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—CREBBP—hematologic cancer	8.73e-07	1.16e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—CREBBP—hematologic cancer	8.68e-07	1.16e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—CYCS—hematologic cancer	8.4e-07	1.12e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—AKT1—hematologic cancer	8.4e-07	1.12e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—PIK3CA—hematologic cancer	8.35e-07	1.11e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—PIK3CA—hematologic cancer	8.35e-07	1.11e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	8.35e-07	1.11e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—PIK3CB—hematologic cancer	8.33e-07	1.11e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—PIK3CD—hematologic cancer	8.28e-07	1.1e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—PIK3CD—hematologic cancer	8.23e-07	1.1e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—PIK3CG—hematologic cancer	8.2e-07	1.09e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—ALB—hematologic cancer	8.17e-07	1.09e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—PIK3R1—hematologic cancer	7.82e-07	1.04e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—PIK3R1—hematologic cancer	7.77e-07	1.04e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—PIK3CA—hematologic cancer	7.65e-07	1.02e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—CREBBP—hematologic cancer	7.6e-07	1.01e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—GSTP1—hematologic cancer	7.41e-07	9.87e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—PIK3CB—hematologic cancer	7.21e-07	9.61e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—PIK3CD—hematologic cancer	7.21e-07	9.61e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—PTEN—hematologic cancer	7.2e-07	9.59e-06	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—PIK3CB—hematologic cancer	7.17e-07	9.56e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—ALB—hematologic cancer	7.12e-07	9.48e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—PIK3CA—hematologic cancer	7.09e-07	9.44e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—ABCB1—hematologic cancer	7.01e-07	9.34e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—EP300—hematologic cancer	6.86e-07	9.14e-06	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—AKT1—hematologic cancer	6.82e-07	9.09e-06	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—AKT1—hematologic cancer	6.82e-07	9.09e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—PIK3R1—hematologic cancer	6.81e-07	9.07e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—NCOR1—hematologic cancer	6.81e-07	9.07e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—GSTM1—hematologic cancer	6.81e-07	9.07e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—PIK3CB—hematologic cancer	6.28e-07	8.37e-06	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—AKT1—hematologic cancer	6.25e-07	8.33e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—PTEN—hematologic cancer	6.23e-07	8.3e-06	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—PTEN—hematologic cancer	6.2e-07	8.26e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—MTHFR—hematologic cancer	6.01e-07	8.01e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—EP300—hematologic cancer	5.94e-07	7.92e-06	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—EP300—hematologic cancer	5.91e-07	7.88e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—AKT1—hematologic cancer	5.79e-07	7.71e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—PTEN—hematologic cancer	5.43e-07	7.24e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—EP300—hematologic cancer	5.18e-07	6.9e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—PIK3CA—hematologic cancer	5.08e-07	6.76e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PIK3CG—hematologic cancer	5.05e-07	6.73e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—CREBBP—hematologic cancer	4.69e-07	6.24e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PIK3CD—hematologic cancer	4.44e-07	5.92e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—PIK3CA—hematologic cancer	4.4e-07	5.86e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—ALB—hematologic cancer	4.39e-07	5.84e-06	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—PIK3CA—hematologic cancer	4.37e-07	5.83e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PIK3R1—hematologic cancer	4.19e-07	5.59e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—AKT1—hematologic cancer	4.15e-07	5.53e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PIK3CB—hematologic cancer	3.87e-07	5.16e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—PIK3CA—hematologic cancer	3.83e-07	5.1e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—AKT1—hematologic cancer	3.59e-07	4.79e-06	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—AKT1—hematologic cancer	3.57e-07	4.76e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PTEN—hematologic cancer	3.35e-07	4.46e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—EP300—hematologic cancer	3.19e-07	4.25e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—AKT1—hematologic cancer	3.13e-07	4.17e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PIK3CA—hematologic cancer	2.36e-07	3.14e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—AKT1—hematologic cancer	1.93e-07	2.57e-06	CbGpPWpGaD
